T. Rowe Price Associates’s BlueLinx BXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$883K Buy
16,281
+1,928
+13% +$127K ﹤0.01% 2216
2025
Q4
$882K Buy
14,353
+4,606
+47% +$297K ﹤0.01% 2137
2025
Q3
$713K Buy
9,747
+346
+4% +$27.3K ﹤0.01% 2217
2025
Q2
$700K Buy
9,401
+107
+1% +$7.48K ﹤0.01% 2145
2025
Q1
$697K Sell
9,294
-17,293
-65% -$1.61M ﹤0.01% 2122
2024
Q4
$2.72M Buy
26,587
+4,539
+21% +$520K ﹤0.01% 1504
2024
Q3
$2.33M Buy
22,048
+14,679
+199% +$1.5M ﹤0.01% 1567
2024
Q2
$686K Buy
7,369
+647
+10% +$68.6K ﹤0.01% 2057
2024
Q1
$876K Buy
6,722
+293
+5% +$34.5K ﹤0.01% 1972
2023
Q4
$729K Buy
6,429
+557
+9% +$48.3K ﹤0.01% 2012
2023
Q3
$483K Buy
5,872
+485
+9% +$42.6K ﹤0.01% 2119
2023
Q2
$506K Buy
5,387
+155
+3% +$12.4K ﹤0.01% 2121
2023
Q1
$356K Buy
5,232
+82
+2% +$6.63K ﹤0.01% 2264
2022
Q4
$366K Sell
5,150
-311
-6% -$21.2K ﹤0.01% 2291
2022
Q3
$340K Buy
5,461
+1,062
+24% +$76.5K ﹤0.01% 2320
2022
Q2
$294K Sell
4,399
-1,102
-20% -$82.8K ﹤0.01% 2446
2022
Q1
$395K Sell
5,501
-934
-15% -$76.5K ﹤0.01% 2441
2021
Q4
$616K Buy
6,435
+774
+14% +$52.4K ﹤0.01% 2294
2021
Q3
$277K Buy
5,661
+71
+1% +$3.57K ﹤0.01% 2612
2021
Q2
$281K Buy
+5,590
New +$275K ﹤0.01% 2614
2015
Q3
Sell
-2,724
Closed -$26K 2516
2015
Q2
$26K Hold
2,724
﹤0.01% 2524
2015
Q1
$29K Hold
2,724
﹤0.01% 2527
2014
Q4
$32K Hold
2,724
﹤0.01% 2526
2014
Q3
$36K Buy
2,724
+1,250
+85% +$15.8K ﹤0.01% 2527
2014
Q2
$21K Buy
1,474
+260
+21% +$3.37K ﹤0.01% 2523
2014
Q1
$16K Hold
1,214
﹤0.01% 2498
2013
Q4
$24K Hold
1,214
﹤0.01% 2477
2013
Q3
$24K Buy
1,214
+100
+9% +$1.9K ﹤0.01% 2453
2013
Q2
$24K Buy
+1,114
New +$28.2K ﹤0.01% 2425

Other funds holding BXC

T. Rowe Price Associates's BXC Position: Q1 2026 in Review

T. Rowe Price Associates increased its BlueLinx (BXC) stake by 13% in Q1 2026, buying an estimated $127K and bringing the position to 16,281 shares worth $883K. The position accounts for ﹤0.01% of the portfolio, ranked #2216.

T. Rowe Price Associates first reported a position in BXC in Q2 2013 and has held it in 29 quarters since. The position peaked at $2.72M in Q4 2024. 145 funds tracked by Wall St. Rank hold BXC as of Q1 2026.

  • T. Rowe Price Associates held 16,281 shares of BlueLinx worth $883K as of Q1 2026.
  • T. Rowe Price Associates bought 1,928 BlueLinx shares in Q1 2026, an estimated $127K.
  • BlueLinx made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #2216 holding.
  • T. Rowe Price Associates first reported a position in BlueLinx in Q2 2013 and has held it in 29 quarters since.
  • T. Rowe Price Associates's BlueLinx position peaked at $2.72M in Q4 2024.
  • 145 funds tracked by Wall St. Rank held BlueLinx as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.